Evogene Company Profile (NYSE:EVGN)

About Evogene

Evogene logoEvogene Ltd. is a plant genomics company. The Company uses an integrated technology infrastructure to enhance seed traits underlying crop performance and productivity through biotechnology and advanced breeding methods. Using its cutting edge computational genomics technologies, ATHLETE, Gene2Product and EvoBreed, the Company specializes in improving traits through applying biotechnology and advanced breeding for a variety of crops. The Company has collaborations with agricultural companies, primarily to develop traits for improved yield and abiotic stress tolerance, such as improved tolerance to drought, heat and salinity and biotic stress resistance, such as resistance to disease, pests and insects), focusing on essential crops, including corn, soybean, wheat, rice and cotton.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: EVGN
  • CUSIP:
Key Metrics:
  • Previous Close: $6.99
  • 50 Day Moving Average: $6.59
  • 200 Day Moving Average: $6.77
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -23.20
  • P/E Growth: 0.00
  • Market Cap: $177.87M
  • Outstanding Shares: 25,447,000
  • Beta: 0.68
Additional Links:
Companies Related to Evogene:

Analyst Ratings

Consensus Ratings for Evogene (NYSE:EVGN) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $9.00 (29.31% upside)

Analysts' Ratings History for Evogene (NYSE:EVGN)
DateFirmActionRatingPrice TargetDetails
8/17/2016Credit Suisse Group AGLower Price TargetOutperform$19.00 -> $10.00View Rating Details
11/19/2015Piper Jaffray Cos.Lower Price TargetNeutral$12.00 -> $8.00View Rating Details
(Data available from 8/24/2014 forward)


Earnings History for Evogene (NYSE:EVGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/11/2016Q2($0.11)($0.18)$5.36 million$3.82 millionViewListenView Earnings Details
5/19/2016Q1($0.11)($0.13)$2.70 million$2.00 millionViewListenView Earnings Details
3/1/2016Q415($0.17)($0.22)$3.90 million$2.46 millionViewN/AView Earnings Details
11/18/2015Q315($0.15)($0.13)$3.50 million$3.31 millionViewListenView Earnings Details
8/5/2015Q215($0.19)($0.20)$4.40 million$2.66 millionViewN/AView Earnings Details
5/19/2015Q115($0.20)($0.13)$3.65 million$2.70 millionViewListenView Earnings Details
2/26/2015Q4($0.12)($0.19)ViewN/AView Earnings Details
11/10/2014Q314($0.11)($0.17)$4.20 million$3.16 millionViewN/AView Earnings Details
8/20/2014Q214($0.11)($0.22)$7.71 millionViewN/AView Earnings Details
5/8/2014Q1 14($0.12)($0.09)ViewN/AView Earnings Details
3/19/2014Q413($0.08)($0.20)$4.95 million$4.41 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Evogene (NYSE:EVGN)
Current Year EPS Consensus Estimate: $-0.54 EPS
Next Year EPS Consensus Estimate: $-0.30 EPS


Dividend History for Evogene (NYSE:EVGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Evogene (NYSE:EVGN)
No insider trades for this company have been tracked by MarketBeat.com


Latest Headlines for Evogene (NYSE:EVGN)
streetinsider.com logoCredit Suisse Cuts Price Target on Evogene (EVGN) to $10 Following 2Q (NYSE:EVGN)
www.streetinsider.com - August 17 at 10:11 PM
capitalcube.com logoEvogene Ltd. :EVGN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NYSE:EVGN)
www.capitalcube.com - August 15 at 5:02 PM
sg.finance.yahoo.com logoEvogene reports 2Q loss (NYSE:EVGN)
sg.finance.yahoo.com - August 11 at 5:03 PM
publicnow.com logoEvogene Reports Second Quarter 2016 Financial Results (NYSE:EVGN)
www.publicnow.com - August 11 at 5:03 PM
publicnow.com logoEvogene Appoints a New Member to Board of Directors and a New Chief Operating Officer (NYSE:EVGN)
www.publicnow.com - August 11 at 5:03 PM
publicnow.com logoEvogene to Participate at Piper Jaffray Global Agriculture Symposium (NYSE:EVGN)
www.publicnow.com - August 1 at 8:11 AM
publicnow.com logoEvogene Second Quarter 2016 Earnings Announcement Schedule (NYSE:EVGN)
www.publicnow.com - July 25 at 8:08 AM
finance.yahoo.com logoEvogene to Present at Crops and Chemicals 2016 Conference (NYSE:EVGN)
finance.yahoo.com - July 13 at 7:00 AM


Evogene (NYSE:EVGN) Chart for Wednesday, August, 24, 2016

Last Updated on 8/24/2016 by MarketBeat.com Staff